Aneta Rogalska

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2014-2024
Publications (10 Years): 20

Top Venues

International journal of molecular sciences

Scientific reports

Cells

TheScientificWorldJournal

University of Lodz

University of Lodz (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

University of Lodz Oct 01 2007

Poland

PhD/Doctor of Biological Sciences in Biophysics :: Department of Medical Biophysics

Education History

University of Lodz Feb 24 2009

Poland

PHD :: Department of Medical Biophysics

Publications

Patrycja Gralewska, Arkadiusz Gajek, Agnieszka Marczak, Aneta Rogalska
Targeted Nanocarrier-Based Drug Delivery Strategies for Improving the Therapeutic Efficacy of PARP Inhibitors against Ovarian Cancer. International journal of molecular sciences 25 (15) (2024)
Łukasz Biegała, Damian Kołat, Arkadiusz Gajek, Elżbieta Płuciennik, Agnieszka Marczak, Agnieszka Sliwinska, Michal Mikula, Aneta Rogalska
Uncovering miRNA-mRNA Regulatory Networks Related to Olaparib Resistance and Resensitization of BRCA2 MUT Ovarian Cancer PEO1-OR Cells with the ATR/CHK1 Pathway Inhibitors. Cells 13 (10) (2024)
Patrycja Gralewska, Arkadiusz Gajek, Agnieszka Marczak, Aneta Rogalska
Targeted Nanocarrier-Based Drug Delivery Strategies for Improving the Therapeutic Efficacy of PARP Inhibitors against Ovarian Cancer. International journal of molecular sciences 25 (15) (2024)
Łukasz Biegała, Damian Kołat, Arkadiusz Gajek, Elżbieta Płuciennik, Agnieszka Marczak, Agnieszka Sliwinska, Michal Mikula, Aneta Rogalska
Uncovering miRNA-mRNA Regulatory Networks Related to Olaparib Resistance and Resensitization of BRCA2 MUT Ovarian Cancer PEO1-OR Cells with the ATR/CHK1 Pathway Inhibitors. Cells 13 (10) (2024)
Łukasz Biegała, Arkadiusz Gajek, Agnieszka Marczak, Aneta Rogalska
Olaparib-Resistant BRCA2 MUT Ovarian Cancer Cells with Restored BRCA2 Abrogate Olaparib-Induced DNA Damage and G2/M Arrest Controlled by the ATR/CHK1 Pathway for Survival. Cells 12 (7) (2023)
Łukasz Biegała, Arkadiusz Gajek, Izabela Szymczak-Pajor, Agnieszka Marczak, Agnieszka Śliwińska, Aneta Rogalska
Targeted inhibition of the ATR/CHK1 pathway overcomes resistance to olaparib and dysregulates DNA damage response protein expression in BRCA2 MUT ovarian cancer cells. Scientific reports 13 (1) (2023)
Łukasz Biegała, Arkadiusz Gajek, Izabela Szymczak-Pajor, Agnieszka Marczak, Agnieszka Śliwińska, Aneta Rogalska
Targeted inhibition of the ATR/CHK1 pathway overcomes resistance to olaparib and dysregulates DNA damage response protein expression in BRCA2 MUT ovarian cancer cells. Scientific reports 13 (1) (2023)
Łukasz Biegała, Arkadiusz Gajek, Izabela Szymczak-Pajor, Agnieszka Marczak, Agnieszka Śliwińska, Aneta Rogalska
Targeted inhibition of the ATR/CHK1 pathway overcomes resistance to olaparib and dysregulates DNA damage response protein expression in BRCA2 MUT ovarian cancer cells. Scientific reports 13 (1) (2023)
Łukasz Biegała, Arkadiusz Gajek, Izabela Szymczak-Pajor, Agnieszka Marczak, Agnieszka Śliwińska, Aneta Rogalska
Targeted inhibition of the ATR/CHK1 pathway overcomes resistance to olaparib and dysregulates DNA damage response protein expression in BRCA2 MUT ovarian cancer cells. Scientific reports 13 (1) (2023)
Patrycja Gralewska, Arkadiusz Gajek, Dorota Rybaczek, Agnieszka Marczak, Aneta Rogalska
The Influence of PARP, ATR, CHK1 Inhibitors on Premature Mitotic Entry and Genomic Instability in High-Grade Serous BRCA MUT and BRCA WT Ovarian Cancer Cells. Cells 11 (12) (2022)
Anastazja Poczta, Piotr Krzeczyński, Joanna Tobiasz, Aneta Rogalska, Arkadiusz Gajek, Agnieszka Marczak
Synthesis and In Vitro Activity of Novel Melphalan Analogs in Hematological Malignancy Cells. International journal of molecular sciences 23 (3) (2022)
Anastazja Poczta, Piotr Krzeczyński, Maksim Ionov, Aneta Rogalska, Udo S Gaipl, Agnieszka Marczak, Dorota Lubgan
Newly Synthesized Melphalan Analogs Induce DNA Damage and Mitotic Catastrophe in Hematological Malignant Cancer Cells. International journal of molecular sciences 23 (22) (2022)
Anastazja Poczta, Aneta Rogalska, Agnieszka Marczak
Treatment of Multiple Myeloma and the Role of Melphalan in the Era of Modern Therapies-Current Research and Clinical Approaches. Journal of clinical medicine 10 (9) (2021)
Patrycja Gralewska, Arkadiusz Gajek, Agnieszka Marczak, Aneta Rogalska
Metformin Affects Olaparib Sensitivity through Induction of Apoptosis in Epithelial Ovarian Cancer Cell Lines. International journal of molecular sciences 22 (19) (2021)
Arkadiusz Gajek, Patrycja Gralewska, Agnieszka Marczak, Aneta Rogalska
Current Implications of microRNAs in Genome Stability and Stress Responses of Ovarian Cancer. Cancers 13 (11) (2021)
Sylwia Michlewska, Maksim Ionov, Aleksandra Szwed, Aneta Rogalska, Natalia Sanz Del Olmo, Paula Ortega, Marta Denel, Damian Jacenik, Dzmitry Shcharbin, Francisco Javier de la Mata, Maria Bryszewska
Ruthenium Dendrimers against Human Lymphoblastic Leukemia 1301 Cells. International journal of molecular sciences 21 (11) (2020)
Patrycja Gralewska, Arkadiusz Gajek, Agnieszka Marczak, Michal Mikula, Jerzy Ostrowski, Agnieszka Sliwinska, Aneta Rogalska
PARP Inhibition Increases the Reliance on ATR/CHK1 Checkpoint Signaling Leading to Synthetic Lethality-An Alternative Treatment Strategy for Epithelial Ovarian Cancer Cells Independent from HR Effectiveness. International journal of molecular sciences 21 (24) (2020)
Anastazja Poczta, Aneta Rogalska, Małgorzata Łukawska, Agnieszka Marczak
Antileukemic activity of novel adenosine derivatives. Scientific reports 9 (1) (2019)
Aneta Rogalska, Ewa Forma, Magdalena Bryś, Agnieszka Śliwińska, Agnieszka Marczak
Hyperglycemia-Associated Dysregulation of O-GlcNAcylation and HIF1A Reduces Anticancer Action of Metformin in Ovarian Cancer Cells (SKOV-3). International journal of molecular sciences 19 (9) (2018)
Aneta Rogalska, Arkadiusz Gajek, Małgorzata Łukawska, Irena Oszczapowicz, Agnieszka Marczak
Novel oxazolinoanthracyclines as tumor cell growth inhibitors-Contribution of autophagy and apoptosis in solid tumor cells death. PloS one 13 (7) (2018)
Aneta Rogalska, Marzena Szwed, Błażej Rychlik
The connection between the toxicity of anthracyclines and their ability to modulate the P-glycoprotein-mediated transport in A549, HepG2, and MCF-7 cells. TheScientificWorldJournal 2014 (2014)

Aneta Rogalska.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Aneta Rogalska